8-K current report · filed Aug 25, 2026

Arcturus Therapeutics Holdings Inc. (ARCT) 8-K Current Report: August 25, 2026

Item 7.01ARCT overview

Short answer

Arcturus Therapeutics Holdings Inc. (ARCT) filed an 8-K current report with the SEC on August 25, 2026 reporting Item 7.01 (Regulation FD Disclosure). ARCT presenting ARCT-810 clinical data in OTC deficiency at the August 25, 2026 SSIM symposium.

Arcturus Therapeutics Holdings Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • ARCT presenting ARCT-810 clinical data in OTC deficiency at the August 25, 2026 SSIM symposium
  • Poster covers dietary intake and biochemical outcomes in adolescents and adults
  • Additional data and regulatory plan expected later this quarter, creating a near-term clinical catalyst
  • ARCT-810 progress could clarify the program’s development path and future regulatory milestones

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Arcturus Therapeutics Holdings Inc. 8-K filings

Get the next ARCT 8-K as it lands

Follow ARCT for push alerts, or ask the research agent what this filing means.